1-6 of 6
Anne Tierens
Close
Sort by
Journal Articles

Optimized cytogenetic risk-group stratification of KMT2A -rearranged pediatric acute myeloid leukemia

Romy E. van Weelderen, Christine J. Harrison, Kim Klein, Yilin Jiang, Jonas Abrahamsson, Todd Alonzo, Richard Aplenc, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Alan Gamis, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J. L. Kaspers
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3200–3213.
https://doi.org/10.1182/bloodadvances.2023011771
Published: 2024
Includes: Supplemental data
Journal Articles

A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria

Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B. Davidson, Mark D. Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1760–1771.
https://doi.org/10.1182/bloodadvances.2023011869
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN

Marta B. Davidson, James A. Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Hassan Sibai, Karen Yee, Anne Tierens, Auro Viswabandya, Vikas Gupta
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1281–1294.
https://doi.org/10.1182/bloodadvances.2023011735
Published: 2024
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data
Journal Articles

Cold agglutinin–associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18

Agnieszka Małecka, Jan Delabie, Ingunn Østlie, Anne Tierens, Ulla Randen, Sigbjørn Berentsen, Geir E. Tjønnfjord, Gunhild Trøen
Journal: Blood Advances
Blood Adv (2020) 4 (6): 993–996.
https://doi.org/10.1182/bloodadvances.2020001608
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

Tracy Murphy, Jinfeng Zou, Georgina S. Daher-Reyes, Andrea Arruda, Vikas Gupta, Caroline J. McNamara, Mark D. Minden, Aaron D. Schimmer, Hassan Sibai, Karen W. L. Yee, Mariam Korulla, Tracy Stockley, Suzanne Kamel-Reid, Dawn Maze, Anne Tierens, Scott V. Bratman, Andre C. Schuh, Steven M. Chan
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2307–2311.
https://doi.org/10.1182/bloodadvances.2019000306
Published: 2019
Includes: Supplemental data